Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. (Record no. 27394076)

MARC details
000 -LEADER
fixed length control field 02476 a2200613 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517164326.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201709s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1879-0852
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ejca.2017.06.029
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cascinu, Stefano
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170911
245 00 - TITLE STATEMENT
Title Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of cancer (Oxford, England : 1990)
Date of publication, distribution, etc. 09 2017
300 ## - PHYSICAL DESCRIPTION
Extent 106-115 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Camptothecin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cetuximab
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colorectal Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorouracil
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Irinotecan
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leucovorin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organoplatinum Compounds
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxaliplatin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rosati, Gerardo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nasti, Guglielmo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lonardi, Sara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zaniboni, Alberto
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marchetti, Paolo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leone, Francesco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bilancia, Domenico
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Iaffaioli, Rosario Vincenzo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zagonel, Vittorina
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giordano, Monica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Corsi, Domenico C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ferraú, Francesco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Labianca, Roberto
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ronzoni, Monica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Scartozzi, Mario
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Galli, Francesca
773 0# - HOST ITEM ENTRY
Title European journal of cancer (Oxford, England : 1990)
Related parts vol. 83
-- p. 106-115
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ejca.2017.06.029">https://doi.org/10.1016/j.ejca.2017.06.029</a>
Public note Available from publisher's website

No items available.